UBS Group relies heavily on fee and non-interest income, a key benefit amid expected future Fed rate cuts. Learn why UBS ...

In this article, GlobalData examines key reimbursement trends that reflect the current delays to patient access across the ...

Glenmark Pharma Ltd. has announced the launch of a blood cancer treatment drug, marketed globally as Brukinsa, after it secured approval from the Drugs Controller General of India (DCGI).

Nyesom Wike-led FCTA is all set to seal the Russian embassy and 33 others. The list of the affected consulates and the reason ...